No. |
KEGG PATHWAY * On map, Yellow: Drug target, Red: Disease-related |
KEGG GENES * |
KEGG DRUG * |
DrugBank |
指定難病告示番号 * |
1 | Acute myeloid leukemia 1 gene, 1 drug (DrugBank) and 4 diseases shown |
1件: RARA |
D06543 |
Vitamin A |
4件: 13, 49, 53, 90 |
2 | Adrenergic signaling in cardiomyocytes 4 genes, 1 drug (DrugBank) and 1 disease shown |
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D01908 |
Nilvadipine |
1件: 90 |
3 | AGE-RAGE signaling pathway in diabetic complications 2 genes, 1 drug (DrugBank) and 2 diseases shown |
2件: VEGFA, VEGFB |
D09574 |
Aflibercept |
2件: 90, 166 |
4 | Alanine, aspartate and glutamate metabolism 4 genes, 1 drug (DrugBank) and 14 diseases shown |
4件: ABAT, ALDH5A1, GAD1, GAD2 |
D00399 |
Valproic Acid |
14件: 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
5 | Alcoholism 3 genes, 2 drugs (DrugBank) and 8 diseases shown |
1件: DDC |
D00558 |
Carbidopa |
8件: 2, 4, 6, 13, 17, 90, 164, 201 |
2件: DRD1, DRD2 |
D00059 |
Levodopa |
7件: 2, 4, 6, 17, 90, 164, 201 |
6 | Aldosterone synthesis and secretion 7 genes, 2 drugs (DrugBank) and 14 diseases shown |
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D01908 |
Nilvadipine |
1件: 90 |
3件: CACNA1G, CACNA1H, CACNA1I |
D00399 |
Valproic Acid |
14件: 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
7 | Alzheimer disease 9 genes, 2 drugs (DrugBank) and 44 diseases shown |
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D01908 |
Nilvadipine |
1件: 90 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
8 | Amphetamine addiction 9 genes, 4 drugs (DrugBank) and 50 diseases shown |
2件: CACNA1C, CACNA1D |
D01908 |
Nilvadipine |
1件: 90 |
1件: DDC |
D00558 |
Carbidopa |
8件: 2, 4, 6, 13, 17, 90, 164, 201 |
1件: DRD1 |
D00059 |
Levodopa |
7件: 2, 4, 6, 17, 90, 164, 201 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
9 | Amyotrophic lateral sclerosis (ALS) 5 genes, 1 drug (DrugBank) and 44 diseases shown |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
10 | Apoptosis - multiple species 1 gene, 1 drug (DrugBank) and 1 disease shown |
1件: NGFR |
D11028 |
Cenegermin |
1件: 90 |
11 | Arrhythmogenic right ventricular cardiomyopathy (ARVC) 4 genes, 1 drug (DrugBank) and 1 disease shown |
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D01908 |
Nilvadipine |
1件: 90 |
12 | Axon guidance 5 genes, 1 drug (DrugBank) and 44 diseases shown |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
13 | B cell receptor signaling pathway 5 genes, 1 drug (DrugBank) and 44 diseases shown |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
14 | beta-Alanine metabolism 3 genes, 1 drug (DrugBank) and 14 diseases shown |
3件: ABAT, GAD1, GAD2 |
D00399 |
Valproic Acid |
14件: 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
15 | Bile secretion 1 gene, 2 drugs (DrugBank) and 6 diseases shown |
1件: CA2 |
D00218 |
Acetazolamide |
6件: 13, 90, 115, 155, 225, 230 |
D01196 |
D00653 |
Dorzolamide |
1件: 90 |
D07871 |
16 | Bladder cancer 1 gene, 1 drug (DrugBank) and 2 diseases shown |
1件: VEGFA |
D09574 |
Aflibercept |
2件: 90, 166 |
17 | Butanoate metabolism 4 genes, 1 drug (DrugBank) and 14 diseases shown |
4件: ABAT, ALDH5A1, GAD1, GAD2 |
D00399 |
Valproic Acid |
14件: 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
18 | C-type lectin receptor signaling pathway 5 genes, 1 drug (DrugBank) and 44 diseases shown |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
19 | Calcium signaling pathway 15 genes, 5 drugs (DrugBank) and 58 diseases shown |
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D01908 |
Nilvadipine |
1件: 90 |
3件: CACNA1G, CACNA1H, CACNA1I |
D00399 |
Valproic Acid |
14件: 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
2件: DRD1, DRD5 |
D00059 |
Levodopa |
7件: 2, 4, 6, 17, 90, 164, 201 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
1件: PTGFR |
D08661 |
Unoprostone |
1件: 90 |
20 | cAMP signaling pathway 7 genes, 2 drugs (DrugBank) and 7 diseases shown |
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D01908 |
Nilvadipine |
1件: 90 |
3件: DRD1, DRD2, DRD5 |
D00059 |
Levodopa |
7件: 2, 4, 6, 17, 90, 164, 201 |
21 | Carbohydrate digestion and absorption 1 gene, 1 drug (DrugBank) and 1 disease shown |
1件: CACNA1D |
D01908 |
Nilvadipine |
1件: 90 |
22 | Cardiac muscle contraction 4 genes, 1 drug (DrugBank) and 1 disease shown |
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D01908 |
Nilvadipine |
1件: 90 |
23 | Cellular senescence 6 genes, 2 drugs (DrugBank) and 44 diseases shown |
1件: CACNA1D |
D01908 |
Nilvadipine |
1件: 90 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
24 | cGMP-PKG signaling pathway 12 genes, 3 drugs (DrugBank) and 44 diseases shown |
3件: ADRA2A, ADRA2B, ADRA2C |
D02076 |
Brimonidine |
1件: 90 |
D07540 |
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D01908 |
Nilvadipine |
1件: 90 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
25 | Chagas disease (American trypanosomiasis) 2 genes, 1 drug (DrugBank) and 7 diseases shown |
2件: IFNGR1, IFNGR2 |
D00747 |
Interferon gamma-1b |
7件: 65, 85, 90, 228, 299, 301, 326 |
26 | Cholinergic synapse 4 genes, 1 drug (DrugBank) and 1 disease shown |
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D01908 |
Nilvadipine |
1件: 90 |
27 | Circadian entrainment 7 genes, 3 drugs (DrugBank) and 21 diseases shown |
2件: CACNA1C, CACNA1D |
D01908 |
Nilvadipine |
1件: 90 |
3件: CACNA1G, CACNA1H, CACNA1I |
D00399 |
Valproic Acid |
14件: 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
2件: MTNR1A, MTNR1B |
D08170 |
Melatonin |
8件: 6, 13, 46, 49, 90, 97, 144, 202 |
28 | Cocaine addiction 3 genes, 2 drugs (DrugBank) and 8 diseases shown |
1件: DDC |
D00558 |
Carbidopa |
8件: 2, 4, 6, 13, 17, 90, 164, 201 |
2件: DRD1, DRD2 |
D00059 |
Levodopa |
7件: 2, 4, 6, 17, 90, 164, 201 |
29 | Collecting duct acid secretion 1 gene, 2 drugs (DrugBank) and 6 diseases shown |
1件: CA2 |
D00218 |
Acetazolamide |
6件: 13, 90, 115, 155, 225, 230 |
D01196 |
D00653 |
Dorzolamide |
1件: 90 |
D07871 |
30 | Cortisol synthesis and secretion 7 genes, 2 drugs (DrugBank) and 14 diseases shown |
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D01908 |
Nilvadipine |
1件: 90 |
3件: CACNA1G, CACNA1H, CACNA1I |
D00399 |
Valproic Acid |
14件: 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
31 | Cushing syndrome 7 genes, 2 drugs (DrugBank) and 14 diseases shown |
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D01908 |
Nilvadipine |
1件: 90 |
3件: CACNA1G, CACNA1H, CACNA1I |
D00399 |
Valproic Acid |
14件: 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
32 | Cytokine-cytokine receptor interaction 3 genes, 2 drugs (DrugBank) and 7 diseases shown |
2件: IFNGR1, IFNGR2 |
D00747 |
Interferon gamma-1b |
7件: 65, 85, 90, 228, 299, 301, 326 |
1件: NGFR |
D11028 |
Cenegermin |
1件: 90 |
33 | Dilated cardiomyopathy (DCM) 4 genes, 1 drug (DrugBank) and 1 disease shown |
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D01908 |
Nilvadipine |
1件: 90 |
34 | Dopaminergic synapse 11 genes, 4 drugs (DrugBank) and 50 diseases shown |
2件: CACNA1C, CACNA1D |
D01908 |
Nilvadipine |
1件: 90 |
1件: DDC |
D00558 |
Carbidopa |
8件: 2, 4, 6, 13, 17, 90, 164, 201 |
5件: DRD1, DRD2, DRD3, DRD4, DRD5 |
D00059 |
Levodopa |
7件: 2, 4, 6, 17, 90, 164, 201 |
3件: PPP3CA, PPP3CB, PPP3CC |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
35 | EGFR tyrosine kinase inhibitor resistance 1 gene, 1 drug (DrugBank) and 2 diseases shown |
1件: VEGFA |
D09574 |
Aflibercept |
2件: 90, 166 |
36 | Estrogen signaling pathway 1 gene, 1 drug (DrugBank) and 4 diseases shown |
1件: RARA |
D06543 |
Vitamin A |
4件: 13, 49, 53, 90 |
37 | Fluid shear stress and atherosclerosis 1 gene, 1 drug (DrugBank) and 2 diseases shown |
1件: VEGFA |
D09574 |
Aflibercept |
2件: 90, 166 |
38 | Focal adhesion 3 genes, 1 drug (DrugBank) and 2 diseases shown |
3件: PGF, VEGFA, VEGFB |
D09574 |
Aflibercept |
2件: 90, 166 |
39 | GABAergic synapse 7 genes, 2 drugs (DrugBank) and 14 diseases shown |
3件: ABAT, GAD1, GAD2 |
D00399 |
Valproic Acid |
14件: 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D01908 |
Nilvadipine |
1件: 90 |
40 | Gap junction 2 genes, 1 drug (DrugBank) and 7 diseases shown |
2件: DRD1, DRD2 |
D00059 |
Levodopa |
7件: 2, 4, 6, 17, 90, 164, 201 |
41 | Gastric acid secretion 1 gene, 2 drugs (DrugBank) and 6 diseases shown |
1件: CA2 |
D00218 |
Acetazolamide |
6件: 13, 90, 115, 155, 225, 230 |
D01196 |
D00653 |
Dorzolamide |
1件: 90 |
D07871 |
42 | Gastric cancer 1 gene, 1 drug (DrugBank) and 4 diseases shown |
1件: RARB |
D06543 |
Vitamin A |
4件: 13, 49, 53, 90 |
43 | Glucagon signaling pathway 5 genes, 1 drug (DrugBank) and 44 diseases shown |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
44 | Glutamatergic synapse 7 genes, 2 drugs (DrugBank) and 44 diseases shown |
2件: CACNA1C, CACNA1D |
D01908 |
Nilvadipine |
1件: 90 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
45 | GnRH secretion 7 genes, 2 drugs (DrugBank) and 14 diseases shown |
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D01908 |
Nilvadipine |
1件: 90 |
3件: CACNA1G, CACNA1H, CACNA1I |
D00399 |
Valproic Acid |
14件: 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
46 | GnRH signaling pathway 4 genes, 1 drug (DrugBank) and 1 disease shown |
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D01908 |
Nilvadipine |
1件: 90 |
47 | Growth hormone synthesis, secretion and action 4 genes, 1 drug (DrugBank) and 1 disease shown |
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D01908 |
Nilvadipine |
1件: 90 |
48 | Herpes simplex virus 1 infection 2 genes, 1 drug (DrugBank) and 7 diseases shown |
2件: IFNGR1, IFNGR2 |
D00747 |
Interferon gamma-1b |
7件: 65, 85, 90, 228, 299, 301, 326 |
49 | HIF-1 signaling pathway 3 genes, 2 drugs (DrugBank) and 8 diseases shown |
2件: IFNGR1, IFNGR2 |
D00747 |
Interferon gamma-1b |
7件: 65, 85, 90, 228, 299, 301, 326 |
1件: VEGFA |
D09574 |
Aflibercept |
2件: 90, 166 |
50 | Human cytomegalovirus infection 6 genes, 2 drugs (DrugBank) and 45 diseases shown |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
1件: VEGFA |
D09574 |
Aflibercept |
2件: 90, 166 |
51 | Human immunodeficiency virus 1 infection 5 genes, 1 drug (DrugBank) and 44 diseases shown |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
52 | Human papillomavirus infection 1 gene, 1 drug (DrugBank) and 2 diseases shown |
1件: VEGFA |
D09574 |
Aflibercept |
2件: 90, 166 |
53 | Human T-cell leukemia virus 1 infection 5 genes, 1 drug (DrugBank) and 44 diseases shown |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
54 | Hypertrophic cardiomyopathy (HCM) 4 genes, 1 drug (DrugBank) and 1 disease shown |
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D01908 |
Nilvadipine |
1件: 90 |
55 | Inflammatory bowel disease (IBD) 2 genes, 1 drug (DrugBank) and 7 diseases shown |
2件: IFNGR1, IFNGR2 |
D00747 |
Interferon gamma-1b |
7件: 65, 85, 90, 228, 299, 301, 326 |
56 | Influenza A 2 genes, 1 drug (DrugBank) and 7 diseases shown |
2件: IFNGR1, IFNGR2 |
D00747 |
Interferon gamma-1b |
7件: 65, 85, 90, 228, 299, 301, 326 |
57 | Insulin secretion 4 genes, 1 drug (DrugBank) and 1 disease shown |
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D01908 |
Nilvadipine |
1件: 90 |
58 | JAK-STAT signaling pathway 2 genes, 1 drug (DrugBank) and 7 diseases shown |
2件: IFNGR1, IFNGR2 |
D00747 |
Interferon gamma-1b |
7件: 65, 85, 90, 228, 299, 301, 326 |
59 | Kaposi sarcoma-associated herpesvirus infection 7 genes, 3 drugs (DrugBank) and 48 diseases shown |
1件: IFNGR1 |
D00747 |
Interferon gamma-1b |
7件: 65, 85, 90, 228, 299, 301, 326 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
1件: VEGFA |
D09574 |
Aflibercept |
2件: 90, 166 |
60 | Leishmaniasis 2 genes, 1 drug (DrugBank) and 7 diseases shown |
2件: IFNGR1, IFNGR2 |
D00747 |
Interferon gamma-1b |
7件: 65, 85, 90, 228, 299, 301, 326 |
61 | Long-term potentiation 6 genes, 2 drugs (DrugBank) and 44 diseases shown |
1件: CACNA1C |
D01908 |
Nilvadipine |
1件: 90 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
62 | MAPK signaling pathway 16 genes, 5 drugs (DrugBank) and 55 diseases shown |
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D01908 |
Nilvadipine |
1件: 90 |
3件: CACNA1G, CACNA1H, CACNA1I |
D00399 |
Valproic Acid |
14件: 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
1件: NGFR |
D11028 |
Cenegermin |
1件: 90 |
3件: PGF, VEGFA, VEGFB |
D09574 |
Aflibercept |
2件: 90, 166 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
63 | Metabolic pathways 18 genes, 4 drugs (DrugBank) and 24 diseases shown |
4件: ABAT, ALDH5A1, GAD1, GAD2 |
D00399 |
Valproic Acid |
14件: 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
13件: CA1, CA12, CA13, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA8, CA9 |
D00218 |
Acetazolamide |
6件: 13, 90, 115, 155, 225, 230 |
D01196 |
D00653 |
Dorzolamide |
1件: 90 |
D07871 |
1件: DDC |
D00558 |
Carbidopa |
8件: 2, 4, 6, 13, 17, 90, 164, 201 |
64 | MicroRNAs in cancer 1 gene, 1 drug (DrugBank) and 2 diseases shown |
1件: VEGFA |
D09574 |
Aflibercept |
2件: 90, 166 |
65 | Morphine addiction 1 gene, 1 drug (DrugBank) and 7 diseases shown |
1件: DRD1 |
D00059 |
Levodopa |
7件: 2, 4, 6, 17, 90, 164, 201 |
66 | Natural killer cell mediated cytotoxicity 7 genes, 2 drugs (DrugBank) and 47 diseases shown |
2件: IFNGR1, IFNGR2 |
D00747 |
Interferon gamma-1b |
7件: 65, 85, 90, 228, 299, 301, 326 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
67 | Necroptosis 2 genes, 1 drug (DrugBank) and 7 diseases shown |
2件: IFNGR1, IFNGR2 |
D00747 |
Interferon gamma-1b |
7件: 65, 85, 90, 228, 299, 301, 326 |
68 | Neuroactive ligand-receptor interaction 12 genes, 8 drugs (DrugBank) and 40 diseases shown |
3件: ADRA2A, ADRA2B, ADRA2C |
D02076 |
Brimonidine |
1件: 90 |
D07540 |
5件: DRD1, DRD2, DRD3, DRD4, DRD5 |
D00059 |
Levodopa |
7件: 2, 4, 6, 17, 90, 164, 201 |
2件: MTNR1A, MTNR1B |
D08170 |
Melatonin |
8件: 6, 13, 46, 49, 90, 97, 144, 202 |
1件: NR3C1 |
D00244 |
Betamethasone |
6件: 2, 46, 65, 90, 96, 235 |
D00972 |
D01357 |
D01402 |
D01637 |
D02032 |
D02286 |
D00292 |
Dexamethasone |
20件: 13, 16, 28, 35, 46, 53, 63, 65, 70, 74, 75, 81, 83, 84, 90, 96, 97, 222, 296, 299 |
D00975 |
D01510 |
D01615 |
D01632 |
D01948 |
D02174 |
D02591 |
D02592 |
D01825 |
Fluocinolone acetonide |
1件: 90 |
D00385 |
Triamcinolone |
18件: 6, 10, 13, 35, 40, 41, 42, 43, 44, 45, 46, 56, 70, 90, 96, 97, 226, 298 |
D00983 |
D00984 |
D00985 |
D06216 |
1件: PTGFR |
D08661 |
Unoprostone |
1件: 90 |
69 | Neurotrophin signaling pathway 1 gene, 1 drug (DrugBank) and 1 disease shown |
1件: NGFR |
D11028 |
Cenegermin |
1件: 90 |
70 | Nitrogen metabolism 13 genes, 2 drugs (DrugBank) and 6 diseases shown |
13件: CA1, CA12, CA13, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA8, CA9 |
D00218 |
Acetazolamide |
6件: 13, 90, 115, 155, 225, 230 |
D01196 |
D00653 |
Dorzolamide |
1件: 90 |
D07871 |
71 | Non-small cell lung cancer 1 gene, 1 drug (DrugBank) and 4 diseases shown |
1件: RARB |
D06543 |
Vitamin A |
4件: 13, 49, 53, 90 |
72 | Oocyte meiosis 5 genes, 1 drug (DrugBank) and 44 diseases shown |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
73 | Osteoclast differentiation 7 genes, 2 drugs (DrugBank) and 47 diseases shown |
2件: IFNGR1, IFNGR2 |
D00747 |
Interferon gamma-1b |
7件: 65, 85, 90, 228, 299, 301, 326 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
74 | Oxytocin signaling pathway 9 genes, 2 drugs (DrugBank) and 44 diseases shown |
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D01908 |
Nilvadipine |
1件: 90 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
75 | Pancreatic cancer 1 gene, 1 drug (DrugBank) and 2 diseases shown |
1件: VEGFA |
D09574 |
Aflibercept |
2件: 90, 166 |
76 | Pancreatic secretion 1 gene, 2 drugs (DrugBank) and 6 diseases shown |
1件: CA2 |
D00218 |
Acetazolamide |
6件: 13, 90, 115, 155, 225, 230 |
D01196 |
D00653 |
Dorzolamide |
1件: 90 |
D07871 |
77 | Parkinson disease 2 genes, 1 drug (DrugBank) and 7 diseases shown |
2件: DRD1, DRD2 |
D00059 |
Levodopa |
7件: 2, 4, 6, 17, 90, 164, 201 |
78 | Pathways in cancer 7 genes, 3 drugs (DrugBank) and 11 diseases shown |
2件: IFNGR1, IFNGR2 |
D00747 |
Interferon gamma-1b |
7件: 65, 85, 90, 228, 299, 301, 326 |
3件: PGF, VEGFA, VEGFB |
D09574 |
Aflibercept |
2件: 90, 166 |
2件: RARA, RARB |
D06543 |
Vitamin A |
4件: 13, 49, 53, 90 |
79 | PD-L1 expression and PD-1 checkpoint pathway in cancer 7 genes, 2 drugs (DrugBank) and 47 diseases shown |
2件: IFNGR1, IFNGR2 |
D00747 |
Interferon gamma-1b |
7件: 65, 85, 90, 228, 299, 301, 326 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
80 | Phenylalanine metabolism 1 gene, 1 drug (DrugBank) and 8 diseases shown |
1件: DDC |
D00558 |
Carbidopa |
8件: 2, 4, 6, 13, 17, 90, 164, 201 |
81 | Phospholipase D signaling pathway 1 gene, 1 drug (DrugBank) and 1 disease shown |
1件: PTGFR |
D08661 |
Unoprostone |
1件: 90 |
82 | PI3K-Akt signaling pathway 4 genes, 2 drugs (DrugBank) and 2 diseases shown |
1件: NGFR |
D11028 |
Cenegermin |
1件: 90 |
3件: PGF, VEGFA, VEGFB |
D09574 |
Aflibercept |
2件: 90, 166 |
83 | Propanoate metabolism 1 gene, 1 drug (DrugBank) and 14 diseases shown |
1件: ABAT |
D00399 |
Valproic Acid |
14件: 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
84 | Proteoglycans in cancer 1 gene, 1 drug (DrugBank) and 2 diseases shown |
1件: VEGFA |
D09574 |
Aflibercept |
2件: 90, 166 |
85 | Proximal tubule bicarbonate reclamation 2 genes, 2 drugs (DrugBank) and 6 diseases shown |
2件: CA2, CA4 |
D00218 |
Acetazolamide |
6件: 13, 90, 115, 155, 225, 230 |
D01196 |
D00653 |
Dorzolamide |
1件: 90 |
D07871 |
86 | Rap1 signaling pathway 5 genes, 3 drugs (DrugBank) and 8 diseases shown |
1件: DRD2 |
D00059 |
Levodopa |
7件: 2, 4, 6, 17, 90, 164, 201 |
1件: NGFR |
D11028 |
Cenegermin |
1件: 90 |
3件: PGF, VEGFA, VEGFB |
D09574 |
Aflibercept |
2件: 90, 166 |
87 | Ras signaling pathway 4 genes, 2 drugs (DrugBank) and 2 diseases shown |
1件: NGFR |
D11028 |
Cenegermin |
1件: 90 |
3件: PGF, VEGFA, VEGFB |
D09574 |
Aflibercept |
2件: 90, 166 |
88 | Relaxin signaling pathway 2 genes, 1 drug (DrugBank) and 2 diseases shown |
2件: VEGFA, VEGFB |
D09574 |
Aflibercept |
2件: 90, 166 |
89 | Renal cell carcinoma 1 gene, 1 drug (DrugBank) and 2 diseases shown |
1件: VEGFA |
D09574 |
Aflibercept |
2件: 90, 166 |
90 | Renin secretion 9 genes, 2 drugs (DrugBank) and 44 diseases shown |
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D01908 |
Nilvadipine |
1件: 90 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
91 | Retrograde endocannabinoid signaling 4 genes, 1 drug (DrugBank) and 1 disease shown |
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D01908 |
Nilvadipine |
1件: 90 |
92 | Rheumatoid arthritis 1 gene, 1 drug (DrugBank) and 2 diseases shown |
1件: VEGFA |
D09574 |
Aflibercept |
2件: 90, 166 |
93 | Salmonella infection 2 genes, 1 drug (DrugBank) and 7 diseases shown |
2件: IFNGR1, IFNGR2 |
D00747 |
Interferon gamma-1b |
7件: 65, 85, 90, 228, 299, 301, 326 |
94 | Serotonergic synapse 5 genes, 2 drugs (DrugBank) and 8 diseases shown |
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D01908 |
Nilvadipine |
1件: 90 |
1件: DDC |
D00558 |
Carbidopa |
8件: 2, 4, 6, 13, 17, 90, 164, 201 |
95 | Small cell lung cancer 1 gene, 1 drug (DrugBank) and 4 diseases shown |
1件: RARB |
D06543 |
Vitamin A |
4件: 13, 49, 53, 90 |
96 | T cell receptor signaling pathway 5 genes, 1 drug (DrugBank) and 44 diseases shown |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
97 | Taste transduction 1 gene, 1 drug (DrugBank) and 1 disease shown |
1件: CACNA1C |
D01908 |
Nilvadipine |
1件: 90 |
98 | Taurine and hypotaurine metabolism 2 genes, 1 drug (DrugBank) and 14 diseases shown |
2件: GAD1, GAD2 |
D00399 |
Valproic Acid |
14件: 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
99 | Th1 and Th2 cell differentiation 7 genes, 2 drugs (DrugBank) and 47 diseases shown |
2件: IFNGR1, IFNGR2 |
D00747 |
Interferon gamma-1b |
7件: 65, 85, 90, 228, 299, 301, 326 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
100 | Th17 cell differentiation 8 genes, 3 drugs (DrugBank) and 48 diseases shown |
2件: IFNGR1, IFNGR2 |
D00747 |
Interferon gamma-1b |
7件: 65, 85, 90, 228, 299, 301, 326 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
1件: RARA |
D06543 |
Vitamin A |
4件: 13, 49, 53, 90 |
101 | Tight junction 1 gene, 1 drug (DrugBank) and 1 disease shown |
1件: CACNA1D |
D01908 |
Nilvadipine |
1件: 90 |
102 | Toxoplasmosis 2 genes, 1 drug (DrugBank) and 7 diseases shown |
2件: IFNGR1, IFNGR2 |
D00747 |
Interferon gamma-1b |
7件: 65, 85, 90, 228, 299, 301, 326 |
103 | Transcriptional misregulation in cancer 2 genes, 2 drugs (DrugBank) and 4 diseases shown |
1件: NGFR |
D11028 |
Cenegermin |
1件: 90 |
1件: RARA |
D06543 |
Vitamin A |
4件: 13, 49, 53, 90 |
104 | Tryptophan metabolism 1 gene, 1 drug (DrugBank) and 8 diseases shown |
1件: DDC |
D00558 |
Carbidopa |
8件: 2, 4, 6, 13, 17, 90, 164, 201 |
105 | Tuberculosis 7 genes, 2 drugs (DrugBank) and 47 diseases shown |
2件: IFNGR1, IFNGR2 |
D00747 |
Interferon gamma-1b |
7件: 65, 85, 90, 228, 299, 301, 326 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
106 | Type I diabetes mellitus 2 genes, 1 drug (DrugBank) and 14 diseases shown |
2件: GAD1, GAD2 |
D00399 |
Valproic Acid |
14件: 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
107 | Type II diabetes mellitus 3 genes, 2 drugs (DrugBank) and 14 diseases shown |
2件: CACNA1C, CACNA1D |
D01908 |
Nilvadipine |
1件: 90 |
1件: CACNA1G |
D00399 |
Valproic Acid |
14件: 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
108 | Tyrosine metabolism 1 gene, 1 drug (DrugBank) and 8 diseases shown |
1件: DDC |
D00558 |
Carbidopa |
8件: 2, 4, 6, 13, 17, 90, 164, 201 |
109 | Valine, leucine and isoleucine degradation 1 gene, 1 drug (DrugBank) and 14 diseases shown |
1件: ABAT |
D00399 |
Valproic Acid |
14件: 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
110 | Vascular smooth muscle contraction 4 genes, 1 drug (DrugBank) and 1 disease shown |
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D01908 |
Nilvadipine |
1件: 90 |
111 | VEGF signaling pathway 6 genes, 2 drugs (DrugBank) and 45 diseases shown |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
1件: VEGFA |
D09574 |
Aflibercept |
2件: 90, 166 |
112 | Wnt signaling pathway 5 genes, 1 drug (DrugBank) and 44 diseases shown |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |